CN108727364A - 一种氢溴酸替格列汀无定型及其制备方法 - Google Patents
一种氢溴酸替格列汀无定型及其制备方法 Download PDFInfo
- Publication number
- CN108727364A CN108727364A CN201810339041.1A CN201810339041A CN108727364A CN 108727364 A CN108727364 A CN 108727364A CN 201810339041 A CN201810339041 A CN 201810339041A CN 108727364 A CN108727364 A CN 108727364A
- Authority
- CN
- China
- Prior art keywords
- lieting
- unformed
- hydrobromates
- method described
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 13
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 title description 8
- 238000000034 method Methods 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 19
- GVLGAFRNYJVHBC-UHFFFAOYSA-N hydrate;hydrobromide Chemical class O.Br GVLGAFRNYJVHBC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 6
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 238000004513 sizing Methods 0.000 claims 1
- 238000005286 illumination Methods 0.000 description 12
- 239000013078 crystal Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 7
- 238000005352 clarification Methods 0.000 description 6
- 150000004677 hydrates Chemical class 0.000 description 6
- 238000000634 powder X-ray diffraction Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- NQPRXLXVOBOTGT-KSLCDFCZSA-N [(2s,4s)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone;hydrate;pentahydrobromide Chemical compound O.Br.Br.Br.Br.Br.O=C([C@H]1NC[C@H](C1)N1CCN(CC1)C1=CC(=NN1C=1C=CC=CC=1)C)N1CCSC1.O=C([C@H]1NC[C@H](C1)N1CCN(CC1)C1=CC(=NN1C=1C=CC=CC=1)C)N1CCSC1 NQPRXLXVOBOTGT-KSLCDFCZSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229950000034 teneligliptin Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229910009112 xH2O Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Description
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710251353 | 2017-04-18 | ||
CN2017102513532 | 2017-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108727364A true CN108727364A (zh) | 2018-11-02 |
Family
ID=63938900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810339041.1A Pending CN108727364A (zh) | 2017-04-18 | 2018-04-16 | 一种氢溴酸替格列汀无定型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108727364A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019205021A1 (zh) * | 2018-04-25 | 2019-10-31 | 乳源东阳光药业有限公司 | 一种氢溴酸替格列汀无定型及其制备方法 |
JP2022069426A (ja) * | 2020-10-23 | 2022-05-11 | マイラン ラボラトリーズ リミテッド | テネリグリプチン2.5臭化水素酸塩のアモルファスを調製する方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101119991A (zh) * | 2005-02-18 | 2008-02-06 | 三菱制药株式会社 | 脯氨酸衍生物的盐,其溶剂合物,及其生产方法 |
CN103649055A (zh) * | 2011-06-01 | 2014-03-19 | 田边三菱制药株式会社 | 用于制备吡唑衍生物的方法 |
CN104230917A (zh) * | 2013-06-24 | 2014-12-24 | 南京华威医药科技开发有限公司 | 一种脯氨酸衍生物盐的水合物及其生产方法 |
WO2015019239A1 (en) * | 2013-08-06 | 2015-02-12 | Ranbaxy Laboratories Limited | Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine |
WO2015132679A1 (en) * | 2014-03-05 | 2015-09-11 | Glenmark Pharmaceuticals Ltd | Teneligliptin compositions |
CN105294673A (zh) * | 2014-06-18 | 2016-02-03 | 四川科伦药物研究院有限公司 | 一种氢溴酸替格列汀的合成方法 |
-
2018
- 2018-04-16 CN CN201810339041.1A patent/CN108727364A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101119991A (zh) * | 2005-02-18 | 2008-02-06 | 三菱制药株式会社 | 脯氨酸衍生物的盐,其溶剂合物,及其生产方法 |
CN103649055A (zh) * | 2011-06-01 | 2014-03-19 | 田边三菱制药株式会社 | 用于制备吡唑衍生物的方法 |
CN104230917A (zh) * | 2013-06-24 | 2014-12-24 | 南京华威医药科技开发有限公司 | 一种脯氨酸衍生物盐的水合物及其生产方法 |
WO2015019239A1 (en) * | 2013-08-06 | 2015-02-12 | Ranbaxy Laboratories Limited | Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine |
WO2015132679A1 (en) * | 2014-03-05 | 2015-09-11 | Glenmark Pharmaceuticals Ltd | Teneligliptin compositions |
CN105294673A (zh) * | 2014-06-18 | 2016-02-03 | 四川科伦药物研究院有限公司 | 一种氢溴酸替格列汀的合成方法 |
Non-Patent Citations (1)
Title |
---|
倪坤仪 主编: "《药物分析化学》", 31 August 2001 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019205021A1 (zh) * | 2018-04-25 | 2019-10-31 | 乳源东阳光药业有限公司 | 一种氢溴酸替格列汀无定型及其制备方法 |
JP2022069426A (ja) * | 2020-10-23 | 2022-05-11 | マイラン ラボラトリーズ リミテッド | テネリグリプチン2.5臭化水素酸塩のアモルファスを調製する方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI711626B (zh) | 達格列淨新穎特別晶型及其製備方法 | |
WO2016184436A1 (zh) | 乐伐替尼甲磺酸盐的新晶型及其制备方法 | |
CN103221411B (zh) | (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型 | |
CN111511371A (zh) | 罗沙司他的多晶型物和共晶 | |
CN110256338A (zh) | 用于制备pde4抑制剂的方法 | |
CN108727364A (zh) | 一种氢溴酸替格列汀无定型及其制备方法 | |
US8252805B2 (en) | Forms of lapatinib ditosylate and processes for preparation thereof | |
CN108727263A (zh) | 硫酸羟氯喹晶型a及其制备方法 | |
WO2013168126A1 (en) | Crystalline forms of vilazodone hydrochloride and vilazodone free base | |
CN108602772A (zh) | 1-(5-(2,4-二氟苯基)-1-((3-氟苯基)磺酰基)-4-甲氧基-1h-吡咯-3-基)-n-甲基甲胺盐新晶型 | |
WO2023040513A1 (zh) | Amg510化合物的晶型及其制备方法和用途 | |
CN101939314B (zh) | 3-吡咯取代的2-吲哚酮的多晶型物 | |
Rodrigues et al. | New Thermoresistant Polymorph from CO 2 Recrystallization of Minocycline Hydrochloride | |
CN104961749A (zh) | 一种头孢呋辛钠的新型工业结晶技术 | |
CN106674079A (zh) | 一种帕比司他的合成方法 | |
CN104961680B (zh) | N‑(4‑{[6,7‑双(甲基氧基)喹啉‑4‑基]氧基}苯基)‑n’‑(4‑氟苯基)环丙烷‑1,1‑二甲酰胺的盐酸盐及其多晶型 | |
WO2022184120A1 (zh) | 羟基酪醇烟酰胺共晶,其制备方法及组合物 | |
CN111303097A (zh) | 二甲胺含笑内酯富马酸盐晶型c及其制备方法 | |
WO2021000687A1 (zh) | Pac-1晶型的制备方法 | |
TWI750119B (zh) | 乾燥白克列無水物之多晶形i之方法 | |
AU2022325334A1 (en) | Crystal form of lanifibranor, preparation method therefor, and use thereof | |
CN104211693B (zh) | 一种利伐沙班晶型及其制备方法与用途 | |
WO2019205021A1 (zh) | 一种氢溴酸替格列汀无定型及其制备方法 | |
CN108101911A (zh) | 一种西格列汀中间体的合成工艺 | |
CN108659038B (zh) | 1-硬脂酰-2-丙戊酰-sn-甘油-3-磷脂酰胆碱的多晶型物及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201214 Address after: Hougongdu Longchuanwan Xiaba Development Zone, Rucheng Town, Ruyuan County, Shaoguan City, Guangdong Province Applicant after: RUYUAN HEC PHARM Co.,Ltd. Address before: 512700 hougongdu Longchuanwan Xiaba Development Zone, Rucheng Town, Ruyuan County, Shaoguan City, Guangdong Province Applicant before: RUYUAN HEC PHARM Co.,Ltd. Applicant before: SUNSHINE LAKE PHARMA Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181102 |